Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Lavoltidine is an orally active and irreversible histamine H2-receptor antagonist. Lavoltidine strongly suppresses gastric acid secretion and also induces hypergastrinemia.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 6-8 weeks | $ 1,520.00 | |
50 mg | 6-8 weeks | $ 1,980.00 | |
100 mg | 6-8 weeks | $ 2,500.00 |
Description | Lavoltidine is an orally active and irreversible histamine H2-receptor antagonist. Lavoltidine strongly suppresses gastric acid secretion and also induces hypergastrinemia. |
In vivo | Lavoltidine inhibits gastric atrophy, hyperplasia, and dysplasia in H felis-infected INS-GAS mice. Lavoltidine treatment for 6 months inhibits gastric tumors in H felis-infected INS-GAS mice. Lavoltidine (Loxtidine; 0.5 g/L; orally (drinking water); changed weekly; 3 months) displays partial suppression of both gastric acid secretion and progression to neoplasia [1]. |
Synonyms | Loxtidine, AH-234844 |
Molecular Weight | 359.47 |
Formula | C19H29N5O2 |
CAS No. | 76956-02-0 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Lavoltidine 76956-02-0 GPCR/G Protein Immunology/Inflammation Neuroscience Histamine Receptor Loxtidine AH-234844 AH 234844 AH234844 inhibitor inhibit